
World · en
China-Developed ALS Therapy Shows Early Trial Promise
In a six-patient trial, a new gene-silencing drug reduced disease-related biomarkers, with no serious adverse events reported.

World · en
In a six-patient trial, a new gene-silencing drug reduced disease-related biomarkers, with no serious adverse events reported.
World · Sky News
World · Nikkei Asia
World · Blaze Media
World · Sky News
World · The Kyiv Independent
Business · Nikkei Asia